In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Update Royal Decree of 7 April 1995 on information and advertising for medicines for human use

Update Royal Decree of 7 April 1995 on information and advertising for medicines for human use

by In2Pharma | Dec 29, 2023 | News

Belgium An update of the Royal Decree of 7 April 1995 on information and advertising for medicines for human use was published to include the degree of “Master in pharmaceutical sciences” as an acceptable degree to obtain the RIP recognition: Source: Royal Decree of 7...
Diploma for the Responsible Person for Information and Publicity (RIP)

Diploma for the Responsible Person for Information and Publicity (RIP)

by In2Pharma | Mar 22, 2023 | News

Belgium The Royal Decree of April 7, 1995 on information and publicity of medicinal products for human use, describing which diplomas are eligible for recognition as RIP is being amended. The adaptation is made to follow the evolution in terminology of the relevant...

Recent Posts

  • Planned legislative updates NL
  • Update RD 06.09.2017 pregabalin/gabapentin
  • Update New Inspection Platform GDP – FAMHP
  • Luxembourg tightens rules on nicotine pouches and novel nicotine products from 2026  
  • Specific claims in NL for food supplements

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België